Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack

• Teresia Hallström,

  Affiliation Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany

  ⨯
• Melanie Uhde,

  Affiliation Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany

  ⨯
• Birendra Singh,

  Affiliation Medical Microbiology, Department of Translational Medicine Malmö, Lund University, Skåne University Hospital, Malmö, Sweden

  ⨯
• Christine Skerka,

  Affiliation Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany

  ⨯
• Kristian Riesbeck,

  Affiliation Medical Microbiology, Department of Translational Medicine Malmö, Lund University, Skåne University Hospital, Malmö, Sweden

  ⨯
• Peter F. Zipfel

  * E-mail: peter.zipfel@hki-jena.de

  Affiliations Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany, Faculty of Biology, Friedrich Schiller University, Jena, Germany

  ⨯